What is the recommended tapering schedule for prednisone (corticosteroid) dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Tapering Recommendations

The optimal prednisone tapering schedule involves reducing the dose to 10 mg/day within 4-8 weeks, followed by a slow taper of 1 mg every 4 weeks until discontinuation. 1

General Principles

  • Prednisone tapering should be individualized based on disease activity, laboratory markers, and potential adverse events 1
  • Single daily dosing is preferred over divided doses to minimize adrenal suppression 1, 2
  • For courses longer than 3 weeks, tapering is necessary to prevent adrenal insufficiency 1
  • Morning administration (before 9 am) is recommended to align with the body's natural cortisol rhythm 2

Specific Tapering Schedules by Initial Dose

For High Initial Doses (>30 mg/day)

  • Reduce to 10 mg/day within 4-8 weeks 3, 1
  • Then taper by 1 mg every 4 weeks until discontinuation 1
  • Alternative approach: Decrease by 5 mg every week until reaching 10 mg/day 1

For Medium Initial Doses (10-30 mg/day)

  • Taper by 5 mg every week until reaching 10 mg/day 1
  • Then slow the taper to 2.5 mg/week until reaching 5 mg/day 1

For Low Doses (<10 mg/day)

  • Taper by 1 mg every 4 weeks 3, 1
  • Alternative approach: Use 1.25 mg decrements with alternate-day schedules (e.g., 10/7.5 mg alternate days) 1

Disease-Specific Recommendations

For Polymyalgia Rheumatica

  • Initial dose: 12.5-25 mg prednisone equivalent daily 3, 1
  • Initial tapering: Reduce to 10 mg/day within 4-8 weeks 3, 1
  • Maintenance tapering: Reduce by 1 mg every 4 weeks until discontinuation 3, 1
  • Some evidence suggests that a rapid taper to 5 mg/day followed by a year at this dose before further tapering may result in lower total prednisone exposure 4

For Inflammatory Conditions

  • Initial dose varies by condition (typically 0.5-1 mg/kg/day) 1
  • For severe conditions: Taper by 10 mg every 2 weeks until reaching 30 mg/day, then by 5 mg every 2 weeks until reaching 20 mg/day, then by 2.5 mg every 2 weeks 1
  • At 10 mg/day, slow to 1 mg every 2-4 weeks until completed 1

Managing Relapse During Tapering

  • Return to the pre-relapse dose that effectively controlled symptoms 3, 5
  • Gradually decrease within 4-8 weeks to the dose at which relapse occurred 3, 5
  • Consider adding steroid-sparing agents if multiple relapses occur 5

Special Considerations

  • For night pain while tapering below 5 mg daily, split doses may be considered 3, 1
  • If withdrawing after long-term therapy, taper gradually rather than abruptly 2
  • Alternate-day therapy (twice the usual daily dose every other morning) may help minimize adrenal suppression during long-term treatment 2
  • Monitor for signs of adrenal insufficiency during tapering 1

Common Pitfalls to Avoid

  • Tapering too quickly, which may lead to disease flare or adrenal insufficiency 1
  • Failing to monitor for steroid-related side effects during tapering 1
  • Not providing patients with clear instructions about tapering schedule 1
  • Continuing treatment without considering steroid-sparing agents in patients requiring prolonged therapy 5

References

Guideline

Prednisone Tapering Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluating an alternative oral regimen for the treatment of polymyalgia rheumatica.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2000

Guideline

Management of Relapsing Polymyalgia Rheumatica

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.